Efficacy of rituximab in secondary progressive multiple sclerosis: Insights from magnetic resonance imaging and disability assessments

Efficacy of rituximab in secondary progressive multiple sclerosis: Insights from magnetic resonance imaging and disability assessments

Background: Although there are a few options for the treatment of patients with secondary progressive multiple sclerosis (SPMS), rituximab (RTX) is used as an off-label treatment. This study aimed to investigate the efficacy of RTX on disability status and volumetric magnetic resonance imaging (MRI)...

Full description

Saved in:
Bibliographic Details
Main Authors: Fereshteh Ashtari, Yousef Mokary, Iman Adibi, Vahid Shaygannejad, Neda Ramezani, Fariba Davanian, Maryam Ahmadi
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2025-07-01
Series:Journal of Research in Medical Sciences
Subjects:
efficacy
magnetic resonance imaging
multiple sclerosis
rituximab
Online Access:https://journals.lww.com/10.4103/jrms.jrms_690_24
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://journals.lww.com/10.4103/jrms.jrms_690_24

Similar Items